In a patient with cardiac disease, what criteria determine when to admit and keep them in the hospital versus when it is safe to discharge them?

Decision Criteria for Admission vs. Discharge of Cardiac Patients

Admit cardiac patients with high-risk features including ongoing ischemia, hemodynamic instability, positive cardiac biomarkers, new ECG changes, heart failure signs, or arrhythmias; discharge low-risk patients with negative serial biomarkers, normal ECG, resolved symptoms, and adequate response to therapy after appropriate observation and risk stratification.

Admission Criteria - When to Keep Patients Hospitalized

Mandatory Admission (High Priority)

For Acute Coronary Syndrome (ACS) patients, admit immediately if any of the following are present 1, 2:

• Ongoing ischemic chest pain despite initial treatment
• Positive cardiac biomarkers (troponin elevation)
• New ST-segment depression or T-wave inversions on ECG
• Hemodynamic instability (systolic BP <90 mmHg, signs of shock)
• Heart failure signs (pulmonary congestion, new/worsening mitral regurgitation)
• Sustained ventricular tachycardia or other life-threatening arrhythmias
• High-risk stress test results
• Left ventricular ejection fraction <40%

For Heart Failure patients, admit if 3:

• Respiratory rate >25 breaths/minute
• Oxygen saturation <90% despite supplemental oxygen
• Systolic blood pressure <90 mmHg
• Signs of hypoperfusion: oliguria, cold peripheries, altered mental status, lactate >2 mmol/L
• BUN ≥43 mg/dL, creatinine ≥2.75 mg/dL, or worsening renal function
• Significantly elevated natriuretic peptides with poor response to initial therapy
• De novo acute heart failure requiring further evaluation

Level of Care Determination

Intensive Care Unit/Coronary Care Unit admission for 2, 3:

• Active ongoing ischemia with hemodynamic compromise
• Cardiogenic shock requiring inotropic support or mechanical circulatory support
• Need for intubation or imminent respiratory failure
• Sustained ventricular arrhythmias

Telemetry/Step-Down Unit for 2:

• Stable patients with confirmed ACS but no active ischemia
• Patients requiring continuous cardiac monitoring without critical instability
• Post-revascularization patients without complications

Discharge Criteria - When Patients Can Safely Leave

Safe Discharge Requirements

For ACS/Chest Pain patients, discharge is appropriate when 2, 4:

• Serial cardiac biomarkers negative (at 0 and 3-6 hours)
• ECG shows no acute changes and remains stable
• No recurrent chest pain during observation period
• Hemodynamically stable for at least 24 hours
• Negative or low-risk stress test (if performed)
• Low-risk score on validated tools (HEART score, TIMI, GRACE)

For Heart Failure patients, discharge when 3:

• Hemodynamically stable with adequate blood pressure
• Euvolemic (no signs of congestion)
• Established on evidence-based oral medications for at least 24 hours
• Stable renal function for at least 24 hours
• Good response to initial therapy: resting heart rate <100 bpm with symptom improvement 3

Post-Revascularization Discharge Timing

After successful PCI: typically discharge next day if uncomplicated course 1, 5

After CABG: generally discharge 4-7 days post-procedure if uncomplicated 1, 5

Critical Discharge Planning Elements

Mandatory Pre-Discharge Actions 1, 5

1. Medication reconciliation: Continue all anti-ischemic medications required during hospitalization
2. Provide sublingual/spray nitroglycerin with usage instructions
3. Patient education on:
   • Warning symptoms requiring emergency care
   • When to use nitroglycerin (if chest pain >2-3 minutes, take one dose; if no relief, call emergency services)
   • Medication purpose, dosing, and side effects
4. Arrange follow-up:
   • Primary care physician within 7 days (ideally within 72 hours) 2, 4
   • Cardiology follow-up within 2 weeks 3
   • Telephone follow-up within 3 days for heart failure patients

Observation Unit Strategy

For intermediate-risk patients 2, 4:

• Use chest pain observation units for 9-12 hour protocol-driven monitoring
• Serial ECGs and cardiac biomarkers
• Discharge if "rule-out" achieved with negative testing
• This approach reduces costs by 63-76% compared to routine admission

Common Pitfalls to Avoid

Do not discharge patients with 2, 3:

• Persistent symptoms despite treatment
• Inadequate social support or inability to follow medication regimen
• Lack of arranged follow-up care
• De novo heart failure without complete evaluation
• Elevated natriuretic peptides without documented improvement

Avoid premature discharge in 6, 7:

• Patients with intermediate or high-risk features (even if initially stable)
• Those without confirmed baseline clinical status
• Patients with complex comorbidities requiring ongoing monitoring

The evidence shows significant disparity between severity assessment and discharge decisions in practice, with quality-of-care targets often not met when discharge criteria are not rigorously applied 7. Risk stratification using validated tools combined with objective measures (biomarkers, ECG, imaging) provides the most reliable framework for admission/discharge decisions, prioritizing patient safety while optimizing resource utilization.